RenBio
0 followers
RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA bluep... Read more
Org chart
Co-Founders
Collapse
Rachel A. Liberatore
President & Chief Scientific Officer
Jim Ackland
Partner
Martin Markowitz
Partner
Meredith Brown-Tuttle
Partner
Sheila Ramerman
Partner
Thanos Papaïoannou
Partner
Marek M. Drozdz
Director of Research
Annelyn P. O’Rourke
Director of Finance & Human Resources
Robert Miller
Director of Development
Andy T. Thompson
Lab Manager
Krystal Ramos
Executive Assistant
